Sensitive and Specific Preclinical Identification of Alzheimer Disease: A Key to Novel Intervention Development
- PMID: 27600364
- PMCID: PMC6386150
- DOI: 10.1016/j.jagp.2016.07.010
Sensitive and Specific Preclinical Identification of Alzheimer Disease: A Key to Novel Intervention Development
Comment on
-
A Novel Cognitive Stress Test for the Detection of Preclinical Alzheimer Disease: Discriminative Properties and Relation to Amyloid Load.Am J Geriatr Psychiatry. 2016 Oct;24(10):804-13. doi: 10.1016/j.jagp.2016.02.056. Epub 2016 Apr 4. Am J Geriatr Psychiatry. 2016. PMID: 27160985 Free PMC article.
References
-
- Boake C (2000). Edouard Claparede and the auditory verbal learning test. [Biography Historical Article]. Journal of clinical and experimental neuropsychology, 22(2), 286–292. - PubMed
-
- Cummings JL, Doody R, & Clark C (2007). Disease-modifying therapies for Alzheimer disease: challenges to early intervention. Neurology, 69(16), 1622–1634. - PubMed
-
- Peters KR, Lynn Beattie B, Feldman HH, & Illes J (2013). A conceptual framework and ethics analysis for prevention trials of Alzheimer Disease. Progress in Neurobiology, 110, 114–123. - PubMed
-
- Riley KP, Snowdon DA, Desrosiers MF, & Markesbery WR (2005). Early life linguistic ability, late life cognitive function, and neuropathology: Findings from the Nun Study. Neurobiology of Aging, 26(3), 341–347. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
